|
HSD17B7P2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.436400E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.997200E-03 |
| Normal-vs-Stage2 |
6.107500E-02 |
| Normal-vs-Stage3 |
5.314600E-01 |
| Normal-vs-Stage4 |
8.344000E-01 |
| Stage1-vs-Stage2 |
5.324600E-01 |
| Stage1-vs-Stage3 |
4.107900E-02 |
| Stage1-vs-Stage4 |
5.136300E-02 |
| Stage2-vs-Stage3 |
1.249420E-01 |
| Stage2-vs-Stage4 |
1.007030E-01 |
| Stage3-vs-Stage4 |
7.888800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.558470E-04 |
| Normal-vs-AfricanAmerican |
5.368200E-02 |
| Normal-vs-Asian |
2.087700E-02 |
| Caucasian-vs-AfricanAmerican |
2.040200E-01 |
| Caucasian-vs-Asian |
6.815400E-01 |
| AfricanAmerican-vs-Asian |
3.604200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.223810E-04 |
| Normal-vs-Female |
2.364000E-02 |
| Male-vs-Female |
1.302550E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.491600E-02 |
| Normal-vs-Extreme_Weight |
1.144210E-02 |
| Normal-vs-Obese |
8.770600E-04 |
| Normal-vs-Extreme_Obese |
7.966800E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.985800E-01 |
| Normal_Weight-vs-Obese |
3.785800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.758200E-01 |
| Extreme_Weight-vs-Obese |
2.707200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.029200E-01 |
| Obese-vs-Extreme_Obese |
1.281380E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.009800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.16700000000137E-05 |
| Normal-vs-Age(61-80Yrs) |
1.784250E-03 |
| Normal-vs-Age(81-100Yrs) |
3.689600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.467800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.980400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.023390E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.012800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.981000E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.827800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.03500000003809E-06 |
| Normal-VS-Type2 PRCC |
9.185400E-01 |
| Normal-VS-KIRP CIMP |
9.411800E-01 |
| Normal-VS-Unclassified PRCC |
7.460000E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.0698000041387E-08 |
| Type1 PRCC-VS-KIRP CIMP |
4.859800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.171200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.945600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.741900E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.037220E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.851700E-02 |
| Normal-vs-N1 |
1.919370E-01 |
| Normal-vs-N2 |
9.714600E-01 |
| N0-vs-N1 |
6.792400E-01 |
| N0-vs-N2 |
4.452600E-01 |
| N1-vs-N2 |
5.519200E-01 |
|
|
